The de novo clustering also split patient samples from the same cancer type, like the glioma samples into clusters G and N: cluster N has elevated mutation rates in TP53 and ATRX which are largely absent from cluster G which instead has elevated rates of CIC as well as even higher rates of IDH1 than N (98% compared to 86%). The gene discussed is ATRX; the disease is glioma.